BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krugliak Cleveland N, Torres J, Rubin DT. What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented? Gastroenterology 2022;162:1396-408. [PMID: 35101421 DOI: 10.1053/j.gastro.2022.01.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Li YY, He YX, Wu YQ, Liu C, Ren LZ, Lu XY, Wang YM, Yu Y. Compatibility between cold-natured medicine CP and hot-natured medicine AZ synergistically mitigates colitis mice through attenuating inflammation and restoring gut barrier. J Ethnopharmacol 2023;303:115902. [PMID: 36395977 DOI: 10.1016/j.jep.2022.115902] [Reference Citation Analysis]
2 Lin G, Yang J, Liu J, Shangguan J, Pan H, Zhang Y, Ran K, Li D, Yu F, Xu H. In situ polyphenol-adhesive hydrogel enhanced the noncarcinogenic repairing of KGF on the gut epithelial barrier on TNBS-induced colitis rats. Int J Biol Macromol 2023;231:123323. [PMID: 36669631 DOI: 10.1016/j.ijbiomac.2023.123323] [Reference Citation Analysis]
3 Ramos L, Teo-Loy J, Barreiro-de Acosta M. Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis. Front Med (Lausanne) 2022;9:1102420. [PMID: 36698823 DOI: 10.3389/fmed.2022.1102420] [Reference Citation Analysis]
4 Wang L, Wang J. Honokiol Ameliorates DSS-Induced Mouse Colitis by Inhibiting Inflammation and Oxidative Stress and Improving the Intestinal Barrier. Oxid Med Cell Longev 2022;2022:1755608. [PMID: 36578522 DOI: 10.1155/2022/1755608] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Krugliak Cleveland N, Bressler B, Siegel CA; BRIDGe UC Progression Summit Collaborators. A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities. Gastroenterology 2022;163:1505-9. [PMID: 35964690 DOI: 10.1053/j.gastro.2022.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li M, Zhang R, Xin M, Xu Y, Liu S, Yu B, Zhang B, Liu J. Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study. Metabolites 2022;12:997. [DOI: 10.3390/metabo12100997] [Reference Citation Analysis]
7 Fairbrass KM, Hamlin PJ, Gracie DJ, Ford AC. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up. Aliment Pharmacol Ther 2022;56:1264-73. [PMID: 35995729 DOI: 10.1111/apt.17193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pal P, Banerjee R, Ramchandani M, Nabi Z, Nageshwar Reddy D, Tandan M. Role of Interventional IBD in Management of Ulcerative Colitis(UC)-Associated Neoplasia and Post-Operative Pouch Complications in UC: A Systematic Review. Ulcerative Colitis [Working Title] 2022. [DOI: 10.5772/intechopen.106599] [Reference Citation Analysis]
9 Sood A, Singh A, Mahajan R, Midha V, Bernstein CN, Rubin DT. (Re)Appraising Remission in Ulcerative Colitis. Inflamm Bowel Dis 2022:izac170. [PMID: 35917172 DOI: 10.1093/ibd/izac170] [Reference Citation Analysis]
10 Hart AL, Rubin DT. Entering the Era of Disease Modification in Inflammatory Bowel Disease. Gastroenterology 2022;162:1367-9. [PMID: 35202593 DOI: 10.1053/j.gastro.2022.02.013] [Reference Citation Analysis]
11 Gu W, Zhang L, Han T, Huang H, Chen J. Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal Model. JIR 2022;Volume 15:2631-47. [DOI: 10.2147/jir.s358807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]